Speculation of a Major Premium Drives Gerresheimer Shares Higher

Gerresheimer shares surge 24% on a potential €40/share bid from Silgan, an 80% premium, despite an ongoing BaFin probe into major accounting irregularities and a postponed annual report.

Shares of the German packaging specialist Gerresheimer have surged on market speculation, temporarily overshadowing the company's significant ongoing accounting crisis. According to a report from the Reuters news agency, U.S. competitor Silgan Holdings is evaluating a potential takeover bid that would value Gerresheimer far above its current trading level.

A Potential Bid at an 80% Premium

The report indicates that Silgan is working on an offer that could exceed €40 per share. This price would represent a premium of approximately 80% over Friday's closing price of €20.94. Investors reacted aggressively to the prospect, sending the stock soaring by more than 24% in a single session before the weekend. The upward momentum continued as trading opened this week. For Silgan, a major manufacturer of food cans, the strategic acquisition would expand its portfolio into the lucrative pharmaceutical and medical packaging sectors.

Fundamental Challenges Remain

However, no formal offer has been made. Any potential acquirer faces the substantial challenge of Gerresheimer's deep regulatory and financial troubles. Germany's financial regulator, BaFin, is currently investigating faulty financial statements for the years 2023 through 2025. The probe centers on discrepancies in revenue recognition, potentially misstated lease liabilities amounting to €65.5 million, and incorrectly capitalized development costs. The company has already warned of potential asset impairments of up to €240 million.

These operational disruptions have direct consequences for shareholders. The dividend for the past fiscal year has been slashed to the legal minimum of €0.04 per share. Furthermore, the submission of the audited annual report has been postponed until after March 31, 2026, which will lead to the company's certain exclusion from the SDAX index.

Shareholder Perspective and Market Performance

Despite the recent sharp gains fueled by takeover talk, the stock remains down 72.47% over a twelve-month horizon. The fundamental risk for investors stays elevated as long as the regulatory review of the company's accounts continues. This uncertainty persists regardless of whether the American suitor ultimately converts its interest into a binding offer.

The market's focus has shifted decisively to the possibility of a lucrative exit via acquisition. Yet, the underlying financial and regulatory issues at Gerresheimer present a complex backdrop for any deal, ensuring that volatility is likely to remain high in the coming weeks.